Eden Research (LON:EDEN) Trading Down 13.2% – Should You Sell?

Posted by ABMN Staff on Apr 1st, 2025

Eden Research plc (LON:EDEN – Get Free Report) dropped 13.2% during mid-day trading on Monday . The company traded as low as GBX 2.26 ($0.03) and last traded at GBX 2.37 ($0.03). Approximately 1,775,147 shares were traded during trading, an increase of 133% from the average daily volume of 762,776 shares. The stock had previously closed at GBX 2.73 ($0.04).

Eden Research Trading Down 2.1 %

The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.26. The company has a market capitalization of £12.27 million, a P/E ratio of -8.06 and a beta of 0.92. The firm’s 50-day moving average price is GBX 3.39 and its 200 day moving average price is GBX 3.72.

Insiders Place Their Bets

In other news, insider Lykele van der Broek acquired 256,000 shares of Eden Research stock in a transaction on Thursday, February 6th. The stock was acquired at an average cost of GBX 4 ($0.05) per share, with a total value of £10,240 ($13,229.97). Also, insider Alexander John Abrey bought 167,947 shares of the company’s stock in a transaction on Tuesday, March 4th. The shares were purchased at an average cost of GBX 3 ($0.04) per share, for a total transaction of £5,038.41 ($6,509.57). In the last ninety days, insiders purchased 964,487 shares of company stock valued at $3,690,001. Corporate insiders own 14.02% of the company’s stock.

About Eden Research

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.